Instituto de Magnetismo Aplicado (IMA)
Centro/Instituto
Hospital Universitario de la Princesa
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de la Princesa (25)
2023
-
Safety and Efficacy of ApTOLL in Patients with Ischemic Stroke Undergoing Endovascular Treatment: A Phase 1/2 Randomized Clinical Trial
JAMA Neurology, Vol. 80, Núm. 8, pp. 779-788
2022
-
First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteers
Molecular Therapy - Nucleic Acids, Vol. 28, pp. 124-135
2015
-
Preliminary research on 1-(4-bromo-2-nitroimidazol-1-yl)-3-[18F]fluoropropan-2-ol as a novel brain hypoxia PET tracer in a rodent model of stroke
European Journal of Medicinal Chemistry, Vol. 101, pp. 604-615
2014
-
Oct-2 transcription factor binding activity and expression up-regulation in rat cerebral ischaemia is associated with a diminution of neuronal damage in vitro
NeuroMolecular Medicine, Vol. 16, Núm. 2, pp. 332-349
-
Rosiglitazone-induced CD36 up-regulation resolves inflammation by PPARγ and 5-LO-dependent pathways
Journal of Leukocyte Biology, Vol. 95, Núm. 4, pp. 587-598
-
The high-mobility group I-Y transcription factor is involved in cerebral ischemia and modulates the expression of angiogenic proteins
Neuroscience, Vol. 269, pp. 112-130
2013
-
Amelioration of Ischemic brain damage by peritoneal dialysis
Journal of Clinical Investigation, Vol. 123, Núm. 10, pp. 4359-4363
-
N2 neutrophils, novel players in brain inflammation after stroke: Modulation by the pparγ agonist rosiglitazone
Stroke, Vol. 44, Núm. 12, pp. 3498-3508
-
Neuronal excitotoxicity after carotid angioplasty and stent placement procedures
Radiology, Vol. 268, Núm. 2, pp. 515-520
2012
2011
-
Longitudinal studies of ischemic penumbra by using 18F-FDG PET and MRI techniques in permanent and transient focal cerebral ischemia in rats
NeuroImage, Vol. 57, Núm. 1, pp. 45-54
2009
-
Synthesis of lipoxin A 4 by 5-lipoxygenase mediates pparγ-dependent, neuroprotective effects of rosiglitazone in experimental stroke
Journal of Neuroscience, Vol. 29, Núm. 12, pp. 3875-3884
2008
-
Activation of liver X receptors promotes neuroprotection and reduces brain inflammation in experimental stroke
Circulation, Vol. 118, Núm. 14, pp. 1450-1459
2007
-
Ischemic preconditioning reveals that GLT1/EAAT2 glutamate transporter is a novel PPARγ target gene involved in neuroprotection
Journal of Cerebral Blood Flow and Metabolism, Vol. 27, Núm. 7, pp. 1327-1338
-
Statin treatment withdrawal in ischemic stroke: A controlled randomized study
Neurology, Vol. 69, Núm. 9, pp. 904-910
2006
-
A polymorphism in the EAAT2 promoter is associated with higher glutamate concentrations and higher frequency of progressing stroke
Journal of Experimental Medicine, Vol. 203, Núm. 3, pp. 711-717
-
High blood pressure and inflammation are associated with poor prognosis in lacunar infarctions
Cerebrovascular Diseases, Vol. 22, Núm. 2-3, pp. 123-129
-
Hyperthermia is a surrogate marker of inflammationmediated cause of brain damage in acute ischaemic stroke
Journal of Internal Medicine, Vol. 260, Núm. 4, pp. 343-349
-
Ischemic preconditioning: A novel target for neuroprotective therapy
Cerebrovascular Diseases, Vol. 21, Núm. SUPPL. 2, pp. 38-47
-
New-onset hypertension and inflammatory response/poor outcome in acute ischemic stroke
Neurology, Vol. 67, Núm. 11, pp. 1973-1978